Equities

Consun Pharmaceutical Group Ltd

Consun Pharmaceutical Group Ltd

Actions
  • Price (HKD)8.49
  • Today's Change-0.17 / -1.96%
  • Shares traded1.05m
  • 1 Year change+86.18%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 06:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,5833,0392,426
Total Receivables, Net310296370
Total Inventory367276243
Prepaid expenses181215
Other current assets, total--02.32
Total current assets4,2783,6233,056
Property, plant & equipment, net739746725
Goodwill, net------
Intangibles, net283312342
Long term investments242216
Note receivable - long term------
Other long term assets------
Total assets5,5084,8924,363
LIABILITIES
Accounts payable836067
Accrued expenses639566466
Notes payable/short-term debt503451599
Current portion long-term debt/capital leases4.223.713.12
Other current liabilities, total266270223
Total current liabilities1,4951,3501,357
Total long term debt3.905.958.55
Total debt512460611
Deferred income tax717869
Minority interest292294293
Other liabilities, total191917
Total liabilities1,8811,7471,745
SHAREHOLDERS EQUITY
Common stock646365
Additional paid-in capital18020
Retained earnings (accumulated deficit)3,5433,0802,561
Treasury stock - common00(30)
Unrealized gain (loss)------
Other equity, total1.842.081.85
Total equity3,6273,1452,618
Total liabilities & shareholders' equity5,5084,8924,363
Total common shares outstanding811807824
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.